Rockwell Medical, Inc.
NASDAQ:RMTI
3.48 (USD) • At close October 21, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Rockwell Medical, Inc. |
Symbool | RMTI |
Munteenheid | USD |
Prijs | 3.475 |
Beurswaarde | 107,829,945 |
Dividendpercentage | 0% |
52-weken bereik | 1.16 - 4.57 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Mark Strobeck Ph.D. |
Website | https://www.rockwellmed.com |
An error occurred while fetching data.
Over Rockwell Medical, Inc.
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)